1. Home
  2. GSIT vs ACIU Comparison

GSIT vs ACIU Comparison

Compare GSIT & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSI Technology

GSIT

GSI Technology

HOLD

Current Price

$7.32

Market Cap

213.6M

Sector

Technology

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.40

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSIT
ACIU
Founded
1995
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6M
213.3M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
GSIT
ACIU
Price
$7.32
$3.40
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
1.8M
418.4K
Earning Date
01-29-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,024,000.00
$5,482,957.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$644.42
P/E Ratio
N/A
N/A
Revenue Growth
22.00
N/A
52 Week Low
$1.62
$1.43
52 Week High
$18.15
$4.00

Technical Indicators

Market Signals
Indicator
GSIT
ACIU
Relative Strength Index (RSI) 48.83 49.89
Support Level $7.10 $3.24
Resistance Level $8.05 $3.90
Average True Range (ATR) 0.91 0.25
MACD -0.07 -0.03
Stochastic Oscillator 18.26 24.24

Price Performance

Historical Comparison
GSIT
ACIU

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: